These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 657716)

  • 41. [Anti-arrhythmia therapy with special reference to quinidine].
    Just H
    Cardiology; 1983; 70 Suppl 1():97-107. PubMed ID: 6189611
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum quinidine concentrations and effect on QT dispersion and interval.
    Mathis AS; Gandhi AJ
    Ann Pharmacother; 2002; 36(7-8):1156-61. PubMed ID: 12086546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR; Kelly RJ; Kovacs JL
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of the efficacy of 2 delayed-action preparations of hydroquinidine and quinidine in the prevention of pacing induced ventricular tachycardia].
    Lévy S; Moyal C; Dolla E; Cointe R; Bru P; Lauribe P; Paganelli F; Chanu P; Gérard R
    Arch Mal Coeur Vaiss; 1993 Sep; 86(9):1359-63. PubMed ID: 8129554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 46. Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.
    Killeen AA; Bowers LD
    Obstet Gynecol; 1987 Sep; 70(3 Pt 2):445-9. PubMed ID: 3627599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antiarrhythmic activity of new 3-[2-(omega-aminoalkoxy)phenoxy]-4-phenyl-3-buten-2-ones and related compounds.
    Salimbeni A; Manghisi E; Fregnan GB; Prada M
    J Med Chem; 1987 May; 30(5):773-80. PubMed ID: 3572966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of quinidine in plasma during quinidine therapy].
    Maagoe H
    Ugeskr Laeger; 1972 Dec; 134(49):2580-3. PubMed ID: 4647030
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

  • 53. Correlation of electrocardiographic changes with plasma quinidine concentration.
    Gonzalez ER; Meyers DG
    Nebr Med J; 1985 Mar; 70(3):87-91. PubMed ID: 3982553
    [No Abstract]   [Full Text] [Related]  

  • 54. Partial synthesis of 6'-hydroxycinchonine and its antiarrhythmic activity in mice.
    Small LD; Rosenberg H; Nwangwu PU; Holcslaw TL; Stohs SJ
    J Med Chem; 1979 Aug; 22(8):1014-6. PubMed ID: 490533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and electrophysiological effects of intravenous quinidine in man.
    Hirschfeld DS; Ueda CT; Rowland M; Scheinman MM
    Br Heart J; 1977 Mar; 39(3):309-16. PubMed ID: 849392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice].
    Iur'ev EG; Iur'eva TI
    Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151
    [No Abstract]   [Full Text] [Related]  

  • 57. Relationship between saliva and serum quinidine concentrations and suppression of ventricular premature beats.
    Ueda CT; Beckmann PJ; Dzindzio BS
    Ther Drug Monit; 1984; 6(1):43-9. PubMed ID: 6200964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
    Edwards DJ; Axelson JE; Visco JP; vanEvery S; Slaughter RL; Lalka D
    Br J Clin Pharmacol; 1987 Mar; 23(3):351-4. PubMed ID: 3567051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of renal transplantation on plasma protein binding.
    Affrime MB; Blecker DL; Lyons PJ; Pitone JM; Swartz CD; Lowenthal DT
    J Dial; 1979; 3(2-3):207-18. PubMed ID: 389974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum quinidine concentrations: comparison of fluorescence, gas-chromatographic, and gas-chromatographic/mass-spectrometric methods.
    Huffman DH; Hignite CE
    Clin Chem; 1976 Jun; 22(6):810-2. PubMed ID: 1277466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.